Thus, the eight gene panel (CXCL12, CK7, CDH1, CTNNB1, CD44v6, MUC16, TGFBR2 and HIF1A) can be a highly significant predictor of liver metastasis outcome independent of the standard prognostic criteria. This evidence concerns the gene MUC16 and medical procedure.